Axsome Therapeutics
AXSM
AXSM
65 hedge funds and large institutions have $216M invested in Axsome Therapeutics in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
86% more funds holding
Funds holding: 35 → 65 (+30)
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
31.69% more ownership
Funds ownership: 12.84% → 44.53% (+32%)
Holders
65
Holding in Top 10
2
Calls
$25.4M
Puts
$8.8M
Top Buyers
| 1 | +$30.6M | |
| 2 | +$11.1M | |
| 3 | +$9.92M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$9.75M |
| 5 |
RI
RTW Investments
New York
|
+$5.53M |
Top Sellers
| 1 | -$3.14M | |
| 2 | -$1.46M | |
| 3 | -$1.39M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$705K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$208K |